Terms: = Cervical cancer AND MYC, c-Myc, 4609, ENSG00000136997 AND Prognosis
54 results:
1. Upregulation of FAM83F by c-myc promotes cervical cancer growth and aerobic glycolysis via Wnt/β-catenin signaling activation.
Zhang C; Liu L; Li W; Li M; Zhang X; Zhang C; Yang H; Xie J; Pan W; Guo X; She P; Zhong L; Li T
Cell Death Dis; 2023 Dec; 14(12):837. PubMed ID: 38104106
[TBL] [Abstract] [Full Text] [Related]
2. Upregulation of SOX9 promotes the self-renewal and tumorigenicity of cervical cancer through activating the Wnt/β-catenin signaling pathway.
Feng Q; Cui N; Li S; Cao J; Chen Q; Wang H
FASEB J; 2023 Oct; 37(10):e23174. PubMed ID: 37668416
[TBL] [Abstract] [Full Text] [Related]
3. HDACs alters negatively to the tumor immune microenvironment in gynecologic cancers.
Yan M; Cao H; Tao K; Xiao B; Chu Y; Ma D; Huang X; Han Y; Ji T
Gene; 2023 Nov; 885():147704. PubMed ID: 37572797
[TBL] [Abstract] [Full Text] [Related]
4. PSME3 induces radioresistance and enhances aerobic glycolysis in cervical cancer by regulating PARP1.
Wei X; Sun K; Li S; Lin C; Wei Z
Tissue Cell; 2023 Aug; 83():102151. PubMed ID: 37467687
[TBL] [Abstract] [Full Text] [Related]
5.
Flores Legarreta A; Salvo G; Gonzales NR; Chisholm G; Hillman RT; Frumovitz M
J Gynecol Oncol; 2023 Jul; 34(4):e50. PubMed ID: 36807750
[TBL] [Abstract] [Full Text] [Related]
6. Morphologic and Molecular Heterogeneity of cervical Neuroendocrine Neoplasia: A Report of 14 Cases.
Ordulu Z; Mino-Kenudson M; Young RH; Van de Vijver K; Zannoni GF; Félix A; Burandt E; Wong A; Nardi V; Oliva E
Am J Surg Pathol; 2022 Dec; 46(12):1670-1681. PubMed ID: 36069807
[TBL] [Abstract] [Full Text] [Related]
7. Loss of PFKFB4 induces cell cycle arrest and glucose metabolism inhibition by inactivating MEK/ERK/c-myc pathway in cervical cancer cells.
Wu Y; Zhang L; Bao Y; Wan B; Shu D; Luo T; He Z
J Obstet Gynaecol; 2022 Aug; 42(6):2399-2405. PubMed ID: 35659173
[TBL] [Abstract] [Full Text] [Related]
8. myc-PDL1 axis reduces sensitivity to nivolumab in recurrent head and neck squamous cell carcinoma.
Noji R; Kano Y; Hirai H; Onishi I; Nishii N; Yoshimura R; Miyake S; Ikeda S; Harada H
Oral Oncol; 2022 Jan; 124():105666. PubMed ID: 34896892
[TBL] [Abstract] [Full Text] [Related]
9. [Clinicopathological features and prognosis of nodal nevi].
Hu J; Ren M; Cai X; Shen XX; Dai B; Kong YY
Zhonghua Bing Li Xue Za Zhi; 2021 May; 50(5):494-499. PubMed ID: 33915657
[No Abstract] [Full Text] [Related]
10. The next generation sequencing of cancer-related genes in small cell neuroendocrine carcinoma of the cervix.
Pei X; Xiang L; Chen W; Jiang W; Yin L; Shen X; Zhou X; Yang H
Gynecol Oncol; 2021 Jun; 161(3):779-786. PubMed ID: 33888337
[TBL] [Abstract] [Full Text] [Related]
11. The therapeutic potential of exosomal miR-22 for cervical cancer radiotherapy.
Konishi H; Hayashi M; Taniguchi K; Nakamura M; Kuranaga Y; Ito Y; Kondo Y; Sasaki H; Terai Y; Akao Y; Ohmichi M
Cancer Biol Ther; 2020 Dec; 21(12):1128-1135. PubMed ID: 33190594
[TBL] [Abstract] [Full Text] [Related]
12. HPV-related methylation-based reclassification and risk stratification of cervical cancer.
Yang S; Wu Y; Wang S; Xu P; Deng Y; Wang M; Liu K; Tian T; Zhu Y; Li N; Zhou L; Dai Z; Kang H
Mol Oncol; 2020 Sep; 14(9):2124-2141. PubMed ID: 32408396
[TBL] [Abstract] [Full Text] [Related]
13. Upregulation of far upstream element-binding protein 1 (FUBP1) promotes tumor proliferation and unfavorable prognosis in tongue squamous cell carcinoma.
Chen Y; Liu J; Geng N; Feng C
Int J Biol Markers; 2020 Jun; 35(2):56-65. PubMed ID: 32339054
[TBL] [Abstract] [Full Text] [Related]
14. The Frequency of Double Expresser in Selected Cases of High Grade Diffuse Large B-Cell Lymphomas.
Naseem M; Asif M; Khadim MT; Ud-Din H; Jamal S; Shoaib I
Asian Pac J Cancer Prev; 2020 Apr; 21(4):1103-1107. PubMed ID: 32334477
[TBL] [Abstract] [Full Text] [Related]
15. Upregulation of long non‑coding RNA CCEPR is associated with poor prognosis and contributes to the progression of ovarian cancer through regulating the Wnt/β‑catenin signaling pathway.
Chen Z; Zhu Y; Fan X; Liu Y; Feng Q
Mol Med Rep; 2020 Apr; 21(4):1950-1958. PubMed ID: 32319633
[TBL] [Abstract] [Full Text] [Related]
16. Long noncoding RNA ROR1‑AS1 overexpression predicts poor prognosis and promotes metastasis by activating Wnt/β-catenin/EMT signaling cascade in cervical cancer.
Zhang L; Yao HR; Liu SK; Song LL
Eur Rev Med Pharmacol Sci; 2020 Mar; 24(6):2928-2937. PubMed ID: 32271410
[TBL] [Abstract] [Full Text] [Related]
17. Treatment of consistent BRAF/HRAS gene mutation and myc amplification radiation-induced abdominal wall angiosarcoma with low-dose apatinib: a case report.
Guan J; Luo Z; Xiao Z; Xie Y; Lin L
BMC Cancer; 2019 Dec; 19(1):1188. PubMed ID: 31805975
[TBL] [Abstract] [Full Text] [Related]
18. Association of iRhom1 and iRhom2 expression with prognosis in patients with cervical cancer and possible signaling pathways.
Xu Q; Chen C; Liu B; Lin Y; Zheng P; Zhou D; Xie Y; Lin Y; Guo C; Liu J; Li L
Oncol Rep; 2020 Jan; 43(1):41-54. PubMed ID: 31661139
[TBL] [Abstract] [Full Text] [Related]
19. Immunohistochemical Biomarkers of Survival in Patients With Adenocarcinoma of the Uterine Cervix Receiving Chemoradiotherapy.
Lin YC; Chen RY; Liang JA; Hung YC; Yeh LS; Chang WC; Lin WC; Chang YY; Chen SW
Anticancer Res; 2019 Jun; 39(6):3231-3240. PubMed ID: 31177173
[TBL] [Abstract] [Full Text] [Related]
20. Potential role of cancer stem cells as biomarkers and therapeutic targets in cervical cancer.
Sudhalkar N; Rathod NP; Mathews A; Chopra S; Sriram H; Shrivastava SK; Goda JS
Cancer Rep (Hoboken); 2019 Apr; 2(2):e1144. PubMed ID: 32721115
[TBL] [Abstract] [Full Text] [Related]
[Next]